Document is current
Any future updates will be listed below
-
Authors
Roemer, Anna
Schlicker, Nadine
Kernder, Anna
Albe, Benedikt
Hack, Juliana
Hirsch, Martin
Mayr, Andreas
Kuhn, Sebastian
Knitza, Johannes
-
Funding
Funding for this research was provided by:
Philipps-Universität Marburg
- License Information
-
More Information
Article History
Received: 19 December 2025
Accepted: 23 March 2026
First Online: 25 March 2026
Declarations
:
: The study complies with the Declaration of Helsinki and was reviewed and deemed exempt from formal approval on August 6th 2024 by the institutional review board of Marburg University, Germany (24–221 ANZ). Informed consent was obtained from all participants prior to enrollment.
: Not applicable.
: Dr Knitza reported receiving research support from Abbvie, Alfasigma, Deutsche Rheumastiftung, GSK and Vila Health outside the submitted work. Dr Kernder reported receiving research support from Novartis, AstraZeneca and AGJR outside the submitted work. Mr Hirsch is a founder of the company Ada Health GmbH and today holds an advisory role.
